Technical Analysis for RTTR - Ritter Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 0.2951 10.32% 0.03
RTTR closed up 10.32 percent on Thursday, September 19, 2019, on 3.28 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Earnings due: Sep 28

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical RTTR trend table...

Date Alert Name Type % Chg
Volume Surge Other 0.00%
Calm After Storm Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish 10.32%
Calm After Storm Range Contraction 10.32%
Narrow Range Bar Range Contraction 10.32%

Older signals for RTTR ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Ritter Pharmaceuticals, Inc. develops novel therapeutic products, which modulate the human gut microbiome to treat inflammatory, gastrointestinal, and metabolic diseases. Its lead product candidate is RP-G28, a novel microbiome modulator, which is under development for the reduction of symptoms associated with lactose intolerance. RP-G28 is designed to stimulate the growth of lactose-metabolizing bacteria in the colon, thereby adapting the gut microbiome to assist in digesting the lactose that reaches the large intestine. RP-G28 has been studied in a Phase 2a clinical trial. The company was formerly known as Ritter Natural Sciences, LLC and changed its name to Ritter Pharmaceuticals, Inc. in September 2008. Ritter Pharmaceuticals, Inc. was founded in 2004 and is headquartered in Los Angeles, California.
Medicine Medical Specialties Therapeutic Products Metabolic Diseases Bacteriology Therapeutic Digestive System Inflammatory Large Intestine Milk
Is RTTR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 2.56
52 Week Low 0.25
Average Volume 515,688
200-Day Moving Average 0.8487
50-Day Moving Average 0.9375
20-Day Moving Average 0.8857
10-Day Moving Average 0.7183
Average True Range 0.1082
ADX 38.54
+DI 11.5446
-DI 48.0957
Chandelier Exit (Long, 3 ATRs ) 0.9054
Chandelier Exit (Short, 3 ATRs ) 0.5746
Upper Bollinger Band 1.5754
Lower Bollinger Band 0.196
Percent B (%b) 0.07
BandWidth 155.741222
MACD Line -0.1699
MACD Signal Line -0.0696
MACD Histogram -0.1003
Fundamentals Value
Market Cap 4.36 Million
Num Shares 14.8 Million
EPS -1.33
Price-to-Earnings (P/E) Ratio -0.22
Price-to-Sales 0.00
Price-to-Book 1.81
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.36
Resistance 3 (R3) 0.36 0.33 0.35
Resistance 2 (R2) 0.33 0.31 0.33 0.35
Resistance 1 (R1) 0.31 0.30 0.32 0.32 0.34
Pivot Point 0.28 0.28 0.29 0.29 0.28
Support 1 (S1) 0.27 0.27 0.28 0.27 0.25
Support 2 (S2) 0.24 0.26 0.24 0.24
Support 3 (S3) 0.22 0.24 0.24
Support 4 (S4) 0.23